Purdue researchers developed a mass spectrometry platform that accelerates cancer drug discovery by integrating synthesis, ...

Researchers and R&D scientists are often sitting on a gold mine of older experiment data, with no good way to extract ...

Researchers at the Purdue Institute for Cancer Research (PICR) have developed a next-generation technology platform designed ...

Today, MALDI-ToF MS is an established technique to characterize and identify pathogenic bacteria. The technique is increasingly applied by clinical microbiological laboratories that use commercially ...

The process of drug discovery encompasses a variety of methods, including experimental, computational, translational, and clinical.  When successful, | Cancer ...

This protocol describes a standardized workflow for multiplexed charge detection mass spectrometry (CDMS) on an Orbitrap analyzer. This allows individual ion mass spectrometry to be performed on a ...

Just how far mass spectrometry—the use of tools measuring the mass-to-charge ratio (m/z) of one or more molecules present in a sample—has progressed over the past century can be seen in a new exhibit ...

Mass spectrometry (MS) has long been a cornerstone of chemical and biological analysis, but in biotech and biomanufacturing, it is now experiencing a renaissance. As drug modalities diversify—peptides ...

Day 1 of the annual meeting of the American Society for Mass Spectrometry (ASMS; NM, USA) has been jam-packed with press conferences from the biggest names in mass spectrometry, and I have been to ...

For biologists, seeing is believing. But sometimes biologists have a hard time seeing. One particularly vexing challenge is seeing all the molecules in an intact tissue sample, down to the level of ...